Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 4
2010 6
2011 8
2012 6
2013 11
2014 5
2015 17
2016 16
2017 7
2018 9
2019 5
2020 23
2021 19
2022 24
2023 21
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Results by year

Filters applied: . Clear all
Page 1
AUTHOR REPLY.
Falcone M, Preto M, Oderda M, Timpano M, Russo IG, Capogrosso P, Cocci A, Fode M, Gontero P; EAU-YAU Men's Health Working Group. Falcone M, et al. Among authors: oderda m. Urology. 2021 Feb;148:316. doi: 10.1016/j.urology.2020.12.012. Epub 2021 Jan 5. Urology. 2021. PMID: 33359489 No abstract available.
AUTHOR REPLY.
Marra G, Marquis A, Calleris G, Oderda M, Gontero P. Marra G, et al. Among authors: oderda m. Urology. 2020 Jun;140:131. doi: 10.1016/j.urology.2019.11.081. Urology. 2020. PMID: 32456862 No abstract available.
Hyperthermia for non-muscle invasive bladder cancer.
Soria F, Allasia M, Oderda M, Gontero P. Soria F, et al. Among authors: oderda m. Expert Rev Anticancer Ther. 2016;16(3):313-21. doi: 10.1586/14737140.2016.1135743. Epub 2016 Jan 21. Expert Rev Anticancer Ther. 2016. PMID: 26713510 Review.
Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer.
Ciccone G, De Luca S, Oderda M, Munoz F, Krengli M, Allis S, Baima CG, Barale M, Bartoncini S, Beldì D, Bellei L, Bellissimo AR, Bernardi D, Biamino G, Billia M, Borsa R, Cante D, Castelli E, Cattaneo G, Centrella D, Collura D, Coppola P, Dalmasso E, Di Stasio A, Fasolis G, Fiorio M, Garibaldi E, Girelli G, Griffa D, Guercio S, Migliari R, Molinaro L, Montefiore F, Montefusco G, Moroni M, Muto G, Ponti di Sant'Angelo F, Ruggiero L, Ruo Redda MG, Serao A, Squeo MS, Stancati S, Surleti D, Varvello F, Volpe A, Zaramella S, Zarrelli G, Zitella A, Bollito E, Gontero P, Porpiglia F, Galassi C, Bertetto O; START Collaborative Group. Ciccone G, et al. Among authors: oderda m. JAMA Netw Open. 2023 Oct 2;6(10):e2338039. doi: 10.1001/jamanetworkopen.2023.38039. JAMA Netw Open. 2023. PMID: 37847502 Free PMC article.
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors.
Falagario UG, Lantz A, Jambor I, Busetto GM, Bettocchi C, Finati M, Ricapito A, Luzzago S, Ferro M, Musi G, Totaro A, Racioppi M, Carbonara U, Checcucci E, Manfredi M, D'Aietti D, Porcaro AB, Nordström T, Björnebo L, Oderda M, Soria F, Taimen P, Aronen HJ, Perez IM, Ettala O, Marchioni M, Simone G, Ferriero M, Brassetti A, Napolitano L, Carmignani L, Signorini C, Conti A, Ludovico G, Scarcia M, Trombetta C, Claps F, Traunero F, Montanari E, Boeri L, Maggi M, Del Giudice F, Bove P, Forte V, Ficarra V, Rossanese M, Mucciardi G, Pagliarulo V, Tafuri A, Mirone V, Schips L, Antonelli A, Gontero P, Cormio L, Sciarra A, Porpiglia F, Bassi P, Ditonno P, Boström PJ, Messina E, Panebianco V, De Cobelli O, Carrieri G; PROMOD Study Group. Falagario UG, et al. Among authors: oderda m. World J Urol. 2023 Nov;41(11):2967-2974. doi: 10.1007/s00345-023-04634-2. Epub 2023 Oct 3. World J Urol. 2023. PMID: 37787941 Free PMC article.
Urinary Zinc Loss Identifies Prostate Cancer Patients.
Maddalone MG, Oderda M, Mengozzi G, Gesmundo I, Novelli F, Giovarelli M, Gontero P, Occhipinti S. Maddalone MG, et al. Among authors: oderda m. Cancers (Basel). 2022 Oct 28;14(21):5316. doi: 10.3390/cancers14215316. Cancers (Basel). 2022. PMID: 36358735 Free PMC article.
145 results